Evolent Health (EVH) Liabilities and Shareholders Equity (2014 - 2026)

Evolent Health has reported Liabilities and Shareholders Equity for 13 years, with the latest figure at $2.0 billion in Q2 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 19.89% year-over-year to $2.0 billion in Q2 2026; TTM through Jun 2026 was $8.2 billion, a 19.27% decrease from a year earlier, with the FY2025 full-year figure at $1.9 billion, down 25.36% from the prior year.
• Liabilities and Shareholders Equity was $2.0 billion for Q2 2026 at Evolent Health, up from $1.9 billion in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $2.7 billion in Q4 2023, with the low at $1.3 billion in Q2 2022.
• Average Liabilities and Shareholders Equity over 5 years is $2.2 billion, with a median of $2.5 billion recorded in 2024.
• The sharpest annual moves came in 2023 and 2026: Liabilities and Shareholders Equity jumped 102.99% in 2023, then retreated 29.19% in 2026.
• Over 5 years, Liabilities and Shareholders Equity stood at $1.8 billion in 2022, then jumped by 47.49% to $2.7 billion in 2023, then dropped by 5.07% to $2.5 billion in 2024, then retreated by 25.36% to $1.9 billion in 2025, then grew by 3.83% to $2.0 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $2.0 billion (Q2 2026), $1.9 billion (Q1 2026), and $1.9 billion (Q4 2025), per Business Quant data.